Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.


Amzal, B., Fu, S., Meng, J. et al. (2 more authors) (2017) Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma. PLoS ONE, 12 (9). e0184423. ISSN 1932-6203

This list was generated on Sat Oct 19 19:05:20 2019 BST.